Avapritinib For Treatment Of Gist

Avapritinib for treatment of GIST (New Drug 2020)

Ranjan Kumar Patel

Discussing the Potential of Novel Agents for Treatment of GIST

Targeted Oncology

Blueprint Medicines GIST Trials: Avapritinib update for the GIST patient and caregiver community

The Life Raft Group

Use of Targeted Therapy in GIST Mutations

SPAEN Annual Conference 22: GIST - Avapritinib & Ripretinib in the treatment algorithm

Sarcoma Patient Advocacy Global Network SPAGN

NH GIST 2023: Two latest GIST therapies: Ripretinib and Avapritinib

Sarcoma Patient Advocacy Global Network SPAGN

GIST Treatment: Durability of Response and Challenges

Update on the NAVIGATOR study

Unmet needs and precision oncology advancements in metastatic GIST

Avapritinib for indolent systemic mastocytosis

VJHemOnc – Video Journal of Hematology & HemOnc

SPAEN Annual Conference 2021: GIST "New compounds in GIST: Avapritinib & Ripretinib"

Sarcoma Patient Advocacy Global Network SPAGN

NAVIGATOR Trial Overview

Targeted Oncology

The Efficacy of Avapritinib to Treat Advanced Systemic Mastocytosis

EXPLORER: Avapritinib in systemic mastocytosis

VJHemOnc – Video Journal of Hematology & HemOnc

AYVAKIT (avapritinib)- Gastrointestinal Stromal Tumor (GIST)

Pharmacy Talk USA

Avapritinib: Mechanism of Action

Adjuvant Treatment in Gastrointestinal Stromal Tumor (GIST)

Standard Treatment Options for Metastatic GIST

Targeted Oncology

GIST: Treatment Considerations

Targeted Oncology

Treatment of KIT exon 9-mutated GISTs